NORTH WALES, Pa.--(BUSINESS WIRE)-- Teva Respiratory announced today the availability of ProAir ® HFA with dose counter for use in patients 4 years of age and older, for the treatment or prevention of ...
A 6-week, randomized, double-blind, placebo-controlled trial compared Proair HFA inhalation aerosol to a matched placebo HFA inhalation aerosol in 95 asthmatic patients 4 to 11 years of age. Patients ...
How Supplied Proair HFA (albuterol sulfate) Inhalation Aerosol is supplied as a pressurized aluminum canister with a red plastic actuator with a dose counter and white dust cap each in boxes of one.
ProAir® HFA was approved by the FDA in October 2004 for treatment or prevention of bronchospasm with reversible obstructive airway disease in adults and children 12 years of age and older. In ...
People with asthma now have a new option to breathe easier. The U.S. Food and Drug Administration this week approved the first generic asthma inhaler as part of its efforts to improve access to ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first generic of ProAir HFA inhalation aerosol — albuterol sulfate — for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results